# Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control

> **NCT03325673** · NA · COMPLETED · sponsor: **Allergan** · enrollment: 84 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DEVICE:** TrueTear
- **DEVICE:** TrueTear Sham Control

## Key facts

- **NCT ID:** NCT03325673
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-22
- **Primary completion:** 2018-11-29
- **Final completion:** 2018-11-29
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2019-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03325673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03325673, "Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03325673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*